Key Findings

The study reports the molecular characterization of FOX-4, a new AmpC-type plasmid-mediated beta-lactamase from an E. coli clinical strain isolated in Spain, which confers resistance to various beta-lactam antibiotics including cefoxitin, ceftazidime, cefotaxime, cefepime, and ciprofloxacin.